We are live on ! Find out more
AAP

Aristotle Atlantic Partners Portfolio holdings

AUM $2.14B
1-Year Est. Return 37.01%
This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+37.01%
3 Year Est. Return
+123.74%
5 Year Est. Return
+154.13%
10 Year Est. Return
AUM
$277M
AUM Growth
-$1.53M
Cap. Flow
+$6.16M
Cap. Flow %
2.22%
Top 10 Hldgs %
60.68%
Holding
99
New
13
Increased
51
Reduced
8
Closed
8

Top Sells

Rank Stock Value
1
DEL
Deltic Timber
DEL
+$7.23M
2
PFE icon
Pfizer
PFE
+$3.78M
3
MRK icon
Merck
MRK
+$2.16M
4
MUR icon
Murphy Oil
MUR
+$1.24M
5
AVGO icon
Broadcom
AVGO
+$419K

Sector Composition

Rank Sector Weight
1 Healthcare 34.11%
2 Industrials 18.07%
3 Energy 16.17%
4 Technology 9.34%
5 Financials 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
1
Merck
MRK
$323B
$37.9M 13.66%
728,370
-40,010
-5% -$2.16M
XOM icon
2
ExxonMobil
XOM
$655B
$24.9M 9%
334,046
-2,000
-0.6% -$160K
UNP icon
3
Union Pacific
UNP
$183B
$21.5M 7.76%
160,000
CELG
4
DELISTED
Celgene Corp
CELG
$15.5M 5.59%
173,661
+174
+0.1% +$16.7K
MUR icon
5
Murphy Oil
MUR
$5.69B
$15.4M 5.57%
597,637
-43,000
-7% -$1.24M
ROP icon
6
Roper Technologies
ROP
$35.9B
$12.4M 4.47%
44,171
+569
+1% +$157K
JPM icon
7
JPMorgan Chase
JPM
$924B
$11.3M 4.09%
103,150
+2,738
+3% +$310K
AME icon
8
Ametek
AME
$55.1B
$10.9M 3.94%
143,677
+2,023
+1% +$154K
TMO icon
9
Thermo Fisher Scientific
TMO
$215B
$10.8M 3.91%
52,524
+518
+1% +$109K
PCH
10
DELISTED
PotlatchDeltic
PCH
$7.39M 2.67%
+142,065
New +$7.39M
GILD icon
11
Gilead Sciences
GILD
$161B
$7.28M 2.63%
96,500
MON
12
DELISTED
Monsanto Co
MON
$7.03M 2.54%
60,200
PH icon
13
Parker-Hannifin
PH
$123B
$5.91M 2.13%
34,564
+413
+1% +$78.2K
AMT icon
14
American Tower
AMT
$77.9B
$5.81M 2.1%
40,000
BA icon
15
Boeing
BA
$164B
$5.72M 2.07%
17,454
+653
+4% +$221K
MSFT icon
16
Microsoft
MSFT
$2.81T
$4.74M 1.71%
51,948
+3,826
+8% +$350K
MUSA icon
17
Murphy USA
MUSA
$11.5B
$3.9M 1.41%
53,558
COO icon
18
Cooper Companies
COO
$13.7B
$3.66M 1.32%
64,000
AAPL icon
19
Apple
AAPL
$4.71T
$3.12M 1.13%
74,340
+7,408
+11% +$319K
SHPG
20
DELISTED
Shire pic
SHPG
$2.89M 1.04%
19,322
+936
+5% +$129K
AGN
21
DELISTED
Allergan plc
AGN
$2.85M 1.03%
16,950
+1,780
+12% +$299K
EOG icon
22
EOG Resources
EOG
$78.3B
$2.83M 1.02%
26,933
+2,060
+8% +$222K
PF
23
DELISTED
Pinnacle Foods, Inc.
PF
$2.7M 0.98%
49,981
+2,371
+5% +$137K
BMRN icon
24
BioMarin Pharmaceuticals
BMRN
$11.4B
$2.63M 0.95%
32,400
IDXX icon
25
Idexx Laboratories
IDXX
$42.6B
$2.59M 0.93%
13,526
+3,067
+29% +$566K

Similar funds

Aristotle Atlantic Partners's Q1 2018 Portfolio in Review

As of Q1 2018, Aristotle Atlantic Partners held 99 positions worth $277M, down 0.55% from $279M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Aristotle Atlantic Partners's Q1 2018 filing shows 13 new, 51 increased, 8 reduced and 8 closed positions. Its largest new stake was PotlatchDeltic: 142,065 shares worth $7.39M. The largest sale was Deltic Timber, an estimated $7.23M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 35% a quarter earlier, followed by Industrials and Energy.

  • Aristotle Atlantic Partners's largest Q1 2018 buy was PotlatchDeltic: 142,065 shares worth $7.39M.
  • Aristotle Atlantic Partners added most to TE Connectivity in Q1 2018, an estimated $1.83M increase.
  • Aristotle Atlantic Partners's biggest Q1 2018 reduction was Merck, cutting an estimated $2.16M.
  • Aristotle Atlantic Partners fully exited Deltic Timber in Q1 2018, selling an estimated $7.23M.
  • Aristotle Atlantic Partners's ten largest holdings make up 61% of its $277M portfolio in Q1 2018.
  • Aristotle Atlantic Partners opened 13 new positions and closed 8 in Q1 2018.
  • Aristotle Atlantic Partners's portfolio value fell 0.55% quarter-over-quarter to $277M.

Based on Aristotle Atlantic Partners's 13F filing for Q1 2018, filed 14 May 2018.